Title:Role of Hydrogen in Atherosclerotic Disease: From Bench to Bedside
Volume: 27
Issue: 5
Author(s): Shucun Qin *
Affiliation:
- The Institute of Atherosclerosis and Taishan Institute for Hydrogen Biomedicine, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian 271000,China
Keywords:
Atherosclerosis, cardiovascular diseases, hydrogen, efficacy response, treatment, prevention, oxidative stress.
Abstract: Atherosclerotic cardiovascular and cerebrovascular diseases are among the leading causes of morbidity
and mortality worldwide. Given our recent understanding of its role as a small-molecule antioxidant and anti-
inflammatory agent, hydrogen may play an important role in preventing and treating atherosclerotic cardiovascular
and cerebrovascular disease. In the past decade, more than 50 publications in the English language literature
considered the role of hydrogen as an anti-atherosclerotic agent. In this review, we summarized the
pathophysiological characteristics and risk factors associated with atherosclerosis (AS) and the laboratory research
data that focuses on hydrogen to prevent and treat this condition, including the responses observed in
both animal models and human studies. We will also consider the molecular mechanisms underlying the efficacy
of hydrogen molecules with respect to atherosclerotic disease. Future studies might include clinical trials
with larger sample populations as well as experiments designed to explore the molecular mechanisms associated
with hydrogen treatment in greater depth.